Evidence map›Paper›PMID 37641628›Full record

ArticleInternational journal of general medicine2023

Impact of the COVID-19 Pandemic on Initiation of Antibiotic Treatment After Performing a Blood Culture and Intervention by the Antimicrobial Stewardship Team.

Sanae Kubota, Hiroshi Sasano, Mai Suzuki, Yukiko Fukui, Masayoshi Chonan, Takaaki Kawakami, Yoko Tabe, Takashi Miida, Toshimi Kimura, Toshio Naito

Open access · goldAbstract read
In one paragraph

Article in International journal of general medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Sanae KubotaDepartment of Pharmacy, Juntendo University Hospital, Tokyo, Japan.
Hiroshi SasanoDepartment of Pharmacy, Juntendo Tokyo Koto Geriatric Medical Center, Tokyo, Japan.ORCID 0000-0002-4450-0280
Mai SuzukiDepartment of General Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan.
Yukiko FukuiDepartment of General Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan.
Masayoshi ChonanDepartment of Clinical Laboratory, Juntendo University Hospital, Tokyo, Japan.
Takaaki KawakamiDepartment of Clinical Laboratory, Juntendo University Hospital, Tokyo, Japan.
Yoko TabeDepartment of Clinical Laboratory Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan.
Takashi MiidaDepartment of Clinical Laboratory Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan.
Toshimi KimuraDepartment of Pharmacy, Juntendo University Hospital, Tokyo, Japan.ORCID 0000-0001-6990-425X
Toshio NaitoDepartment of General Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan.ORCID 0000-0003-1646-9930
Juntendo University · JPJuntendo University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Whether the coronavirus disease 2019 (COVID-19) pandemic had any effect on the time between blood culture collection and administration of antibiotics in the outpatient Department of Emergency Medicine in a single university hospital in Japan was investigated, and the intervention carried out by the antimicrobial stewardship team (AST) to promote the appropriate use of antibiotics was examined. Patients and Methods: The monthly percentage of patients who visited the outpatient Department of Emergency Medicine between January 2019 and December 2021 and received an intravenous antibiotic within 3 hours of blood culture collection was calculated. The AST calculated a quality indicator (QI) based on the results of the investigation and started QI monitoring and hospital feedback. Results: From January 2020 to March 2021 (the third COVID-19 wave), the implementation rate of antibiotic administration within 3 hours after blood culture collection decreased as the COVID-19 pandemic spread, and the implementation rate tended to increase as the number of COVID-19-positive patients decreased. However, when the AST started monitoring and feedback from April 2021, although there was a temporary decline in the early stages of the fifth wave when the scale of infection was large, the implementation rate rose and was maintained by AST intervention. (the fourth and the fifth COVID-19 waves) (P<0.01). Also, the implementation rate was significantly lower during the COVID-19 pandemic than during the non- pandemic (P<0.05). Conclusion: The early COVID-19 pandemic may have affected the delay in time from blood culture collection to antibiotic administration. Later, in recurring COVID-19 pandemics, AST intervention eliminated this problem. When a bacterial infection such as sepsis is suspected, delayed treatment can be prevented by promptly collecting a blood culture, irrespective of concerns about COVID-19 infection. Calculating the QI may promote AST activities and the appropriate use of antibiotics.

Indexed as

administration of antibioticsbacteremiacoronavirus disease 2019quality indicator

Identifiers

PMID37641628
PMCPMC10460591
OpenAlexW4386101015

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.